João Bocas – The Wearables Expert ™ interviews Charles Michael Gibson, MD. CEO of Baim Institute for Clinical Research, (FKA Harvard Clinical Research Institute and Perfus). Professor of Medicine – Harvard Medical School. Founder & Editor in Chief WikiDoc.Org
In this episode, Joao talks about #Virtual #ClinicalTrials as opposed to traditional trials. We discuss the cost and also the main advantages in going virtual and moving to the electronic and digital world. Mike also gave amazing insights on Big Data, Data generated by #Wearables and the need to work together. Here are the questions Joao asked Dr. Gibson: 01:24 What are the forces driving the adaptation of virtual clinical trials and clinical trials? 02:52 How does a virtual clinical trial differ from a traditional clinical trial? 13:07 How do you see the future?
Connect with Dr. Gibson: LinkedIn: https://www.linkedin.com/in/cmichaelg… Twitter: https://twitter.com/CMichaelGibson Website: www.wikidoc.org
India is no longer simply a market to watch. It is a nation shaping the…
When GLP-1 medications like semaglutide began to gain attention, many people saw them as a…
At the end of last year, I was lucky enough to get an insight into…
Healthcare today is increasingly shaped by actuarial logic rather than human outcomes. Coverage decisions are…
Not long ago, a physician’s most powerful instrument was not a machine, an algorithm, or…
When GLP-1 medications like semaglutide began to gain attention, many people saw them as a…
This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.
Read More